Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 3190183)

Published in Anat Rec (Hoboken) on September 08, 2011

Authors

Gene J Blatt1, S Hossein Fatemi

Author Affiliations

1: Department of Anatomy and Neurobiology, Laboratory for Autism Neuroscience Research, Boston University School of Medicine, Massachusetts, USA. gblatt@bu.edu

Articles citing this

Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc Natl Acad Sci U S A (2012) 1.79

Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci (2013) 1.20

Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature (2014) 1.14

Epigenetics in the human brain. Neuropsychopharmacology (2012) 1.08

The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. Int J Environ Res Public Health (2013) 1.07

Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull (2013) 1.00

GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism. Neuropsychopharmacology (2015) 0.97

Use of transcranial magnetic stimulation in autism spectrum disorders. J Autism Dev Disord (2015) 0.93

Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorder. Front Hum Neurosci (2014) 0.93

Biomarkers in autism. Front Psychiatry (2014) 0.92

Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation (2014) 0.90

Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum. Mol Autism (2014) 0.88

Cortical variability in the sensory-evoked response in autism. J Autism Dev Disord (2015) 0.87

Children with autism spectrum disorders show abnormal conditioned response timing on delay, but not trace, eyeblink conditioning. Neuroscience (2013) 0.87

Inhibition-Based Biomarkers for Autism Spectrum Disorder. Neurotherapeutics (2015) 0.86

Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci (2014) 0.85

Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases. Neuroscience (2012) 0.83

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders. Front Neurosci (2016) 0.83

Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children. Eur Child Adolesc Psychiatry (2013) 0.82

Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model. Int J Neuropsychopharmacol (2015) 0.82

Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics (2015) 0.82

Gestational vitamin D deficiency and autism-related traits: the Generation R Study. Mol Psychiatry (2016) 0.81

Behavioral training reverses global cortical network dysfunction induced by perinatal antidepressant exposure. Proc Natl Acad Sci U S A (2015) 0.80

Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. Neuropharmacology (2012) 0.80

Changes in plasticity across the lifespan: cause of disease and target for intervention. Prog Brain Res (2013) 0.79

Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning. PLoS One (2013) 0.79

GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. Schizophr Res (2014) 0.79

DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. Int J Mol Sci (2016) 0.79

Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability. Behav Brain Res (2016) 0.78

DNA Methylation Profiling at Single-Base Resolution Reveals Gestational Folic Acid Supplementation Influences the Epigenome of Mouse Offspring Cerebellum. Front Neurosci (2016) 0.77

Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects. Hum Mol Genet (2016) 0.77

Early Postnatal Lipopolysaccharide Exposure Leads to Enhanced Neurogenesis and Impaired Communicative Functions in Rats. PLoS One (2016) 0.76

An ecological study on childhood autism. Int J Health Geogr (2012) 0.76

Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia. Schizophr Res (2014) 0.76

Insulin-Independent GABAA Receptor-Mediated Response in the Barrel Cortex of Mice with Impaired Met Activity. J Neurosci (2016) 0.75

Autistic-Like Behaviors, Oxidative Stress Status, and Histopathological Changes in Cerebellum of Valproic Acid Rat Model of Autism Are Improved by the Combined Extract of Purple Rice and Silkworm Pupae. Oxid Med Cell Longev (2016) 0.75

Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach. Neuropsychiatry (London) (2013) 0.75

Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model. J Clin Psychopharmacol (2016) 0.75

Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders. J Dev Behav Pediatr (2016) 0.75

Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. Amino Acids (2016) 0.75

Rapid and Objective Assessment of Neural Function in Autism Spectrum Disorder Using Transient Visual Evoked Potentials. PLoS One (2016) 0.75

Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder. Transl Psychiatry (2017) 0.75

Articles cited by this

A clinicopathological study of autism. Brain (1998) 3.49

Epilepsy in autism. Lancet Neurol (2002) 2.93

Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet (2004) 2.89

Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem (1991) 2.66

Histoanatomic observations of the brain in early infantile autism. Neurology (1985) 2.29

GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord (2008) 2.23

Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet (1998) 2.16

Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci (1998) 2.09

15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum Mol Genet (2007) 1.99

Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord (2001) 1.98

Microcircuitry and function of the inferior olive. Trends Neurosci (1998) 1.82

Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol (2007) 1.71

Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry (1986) 1.65

Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum (2009) 1.64

Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum (2008) 1.61

Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2007) 1.58

The contribution of neuropathologic studies to the understanding of autism. Neurol Clin (1993) 1.57

Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children. Brain Dev (1993) 1.57

Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol Neurobiol (2002) 1.51

Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res (2009) 1.30

Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J Comp Neurol (1993) 1.26

A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. Am J Med Genet B Neuropsychiatr Genet (2004) 1.23

Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol (1980) 1.19

Autism and Asperger's disorder: are they movement disorders involving the cerebellum and/or basal ganglia? Brain Res Bull (2005) 1.17

Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism. Acta Neurol Scand (2009) 1.15

Increased GAD67 mRNA expression in cerebellar interneurons in autism: implications for Purkinje cell dysfunction. J Neurosci Res (2008) 1.11

The GABAergic cerebello-olivary projection in the rat. Anat Embryol (Berl) (1991) 1.08

Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy. Eur J Neurosci (2003) 1.07

Some afferent connections of the oculomotor complex in the cat: an experimental study with tracer techniques. Brain Res (1974) 1.05

Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience (1981) 1.04

Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells. J Neurosci Res (2009) 1.02

Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res (2009) 1.02

Morphological correlates of bilateral synchrony in the rat cerebellar cortex. J Neurosci (1996) 1.01

[3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study. J Autism Dev Disord (2007) 0.98

Cerebellar nucleo-olivary projections in the rat: an anterograde tracing study with Phaseolus vulgaris-leucoagglutinin (PHA-L). J Comp Neurol (1990) 0.96

Colocalization of neurotransmitters in the deep cerebellar nuclei. J Neurocytol (1993) 0.94

A new combination of WGA-HRP anterograde tracing and GABA immunocytochemistry applied to afferents of the cat inferior olive at the ultrastructural level. Brain Res (1988) 0.92

Functional significance of climbing-fiber synchrony: a population coding and behavioral analysis. Ann N Y Acad Sci (2002) 0.91

Differential number of glycine- and GABA-immunopositive neurons and terminals in the deep cerebellar nuclei of normal and Purkinje cell degeneration mutant mice. J Comp Neurol (1997) 0.88

Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res (2003) 0.88

Successive alterations of hippocampal gamma-aminobutyric acid B receptor subunits in a rat model of febrile seizure. Life Sci (2005) 0.86

Sources of descending afferents to the inferior olive from the upper brain stem in the cat as revealed by the retrograde transport of horseradish peroxidase. J Comp Neurol (1981) 0.83

Organizational features of the cat and monkey cerebellar nucleocortical projection. J Comp Neurol (1978) 0.83

Short-term control of GABA synthesis in brain. Prog Biophys Mol Biol (1993) 0.81

Articles by these authors

Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci (2003) 3.50

In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev (2009) 1.74

Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia. Schizophr Res (2010) 1.52

The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology (2012) 1.32

Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res (2010) 1.05

Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol (2003) 1.03

Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol (2008) 0.98

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96

Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96

Expression of phosphodiesterase 4 is altered in the brains of subjects with autism. Neuroreport (2007) 0.94

Varenicline efficacy and tolerability in a subject with schizophrenia. Schizophr Res (2008) 0.91

Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol (2007) 0.87

A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia. J Addict Res Ther (2011) 0.86

Phosphodiesterase signaling system is disrupted in the cerebella of subjects with schizophrenia, bipolar disorder, and major depression. Schizophr Res (2010) 0.83

Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero. Schizophr Res (2004) 0.82

Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study. Schizophr Res (2013) 0.80

Reelin, a marker of stress resilience in depression and psychosis. Neuropsychopharmacology (2011) 0.79

Cerebellum and autism. Cerebellum (2013) 0.78

Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism. J Neuroimmunol (2009) 0.76